Home › Funds › PERCEPTIVE ADVISORS LLC › ZYME

PERCEPTIVE ADVISORS LLC position in ZYME

ZYMEWORKS INC · Health Care

PERCEPTIVE ADVISORS LLC reported holding 4,182,953 shares of ZYME (ZYMEWORKS INC) in its Q2 2026 13F filing — a position valued at US$109.3M, representing 1.73% of its reported portfolio and ranking #18 among its reported holdings. PERCEPTIVE ADVISORS LLC has disclosed ZYME holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)4.18M sh
Reported value held$109.34M
Portfolio Weight1.73%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How PERCEPTIVE ADVISORS LLC's ZYME position evolved

PERCEPTIVE ADVISORS LLC first disclosed a stake in ZYME in Q3 2023 at 1,446,123 shares (US$9.2M). The position peaked in Q2 2026 at 4,182,953 shares, worth US$109.3M. Across 12 filings, PERCEPTIVE ADVISORS LLC increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 4,182,953 shares valued at US$109.3M — an increase of 672,875 shares quarter over quarter.. Notable position changes include a 55% increase in Q2 2024 (shares rose 47% over the following quarter), a 64% increase in Q3 2025 (shares rose 54% over the following quarter), a 56% increase in Q4 2025 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.45M $9.17M New
Q4 2023 1.07M $11.17M Reduce
Q1 2024 1.07M $11.31M Hold
Q2 2024 1.67M $14.19M Add
Q3 2024 2.18M $27.36M Add
Q4 2024 2.13M $31.18M Reduce
Q1 2025 1.86M $22.21M Reduce
Q2 2025 1.28M $16.00M Reduce
Q3 2025 2.09M $35.71M Add
Q4 2025 3.26M $85.88M Add
Q1 2026 3.51M $87.89M Add
Q2 2026 4.18M $109.34M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ZYME and 13F data

ZYME (ZYMEWORKS INC) is a Health Care company. 30 other funds we track also report a position in ZYME — the largest reported positions include EcoR1 Capital, LLC (US$600.4M), Rubric Capital Management LP (US$183.0M), BVF INC/IL (US$95.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ZYME

All ZYME fund holders →

FAQ

How long has PERCEPTIVE ADVISORS LLC held ZYME?

PERCEPTIVE ADVISORS LLC has disclosed ZYME holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is PERCEPTIVE ADVISORS LLC's current position in ZYME?

As of Q2 2026, PERCEPTIVE ADVISORS LLC holds 4.18M shares of ZYME (ZYMEWORKS INC), valued at $109.34M, representing 1.73% of its reported portfolio and ranking #18.

Has PERCEPTIVE ADVISORS LLC been buying or selling ZYME?

In the latest 13F filing (Q2 2026), PERCEPTIVE ADVISORS LLC increased its position in ZYME. The position peaked in Q2 2026 at 4.18M shares.

Which other funds hold ZYME?

Other major institutional holders of ZYME include EcoR1 Capital, LLC, Rubric Capital Management LP, BVF INC/IL, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.